Minimally Invasive Treatment of Dupuytren Contracture: Collagenase Versus PNF
PNF collagenase Patients 48 23 25 Male: female 39:9 19:4 20:5 Age 69 72 (54–80) 67 (49–79) Right: left hand 27:21 11:12 16:9 Table 34.2 Patients at 24 months…
PNF collagenase Patients 48 23 25 Male: female 39:9 19:4 20:5 Age 69 72 (54–80) 67 (49–79) Right: left hand 27:21 11:12 16:9 Table 34.2 Patients at 24 months…
Fig. 38.1 Placement of the Digit WidgetTM. The Digit WidgetTM is placed on the dorsal mid-longitudinal axis. Placement under fluoroscopy assures the device is placed in good position and that…
1. Proliferating mitogenic fibroblasts/myofibroblasts are radiosensitive cells (Rodemann et al. 1991; Rodemann and Bamberg 1995; Rubin et al. 1999) 2. Production of free radicals impair proliferative activity of fibroblasts (Murrell…
Fig. 37.1 Model 1 (simple model) Fig. 37.2 Model 2 (including details on complications) 37.3 Results The questionnaire to assess the models was answered by 27 orthopedic surgeons. Only five…
Fig. 5.1 Geographical distribution of participants with Dupuytren Disease 5.3.1 Gender-Dependent Age of Onset The average age of onset of Dupuytren Disease of all patients was 47.7 (median = 49)….
Fig. 44.1 A dorsal hand-based thermoplastic splint Fig. 44.2 A volar hand-based thermoplastic splint 44.2.3 The Role of Postoperative Splinting Some surgeons routinely advise postoperative splinting after fasciectomy and dermofasciectomy….
Fig. 42.1 Severe Dupuytren contracture of the little finger. This situation is presenting a difficult surgical approach; ankylosis of MP and IPP joints; contracture with important loss of digito-palmar and…
Fig. 26.1 QuickDASH In an effort to find a scale which is more valid in DD, we developed the Southampton Dupuytren’s Scoring Scheme (SDSS). This was derived by reducing many…
Recruit patients Enrollment survey Follow-up surveys Directly Demographics Changes in E-mail Age, sex, race Social history SMS Handedness Medical history Social media Social history Medications Newswire Medical history Garrod pads…
MP joints Clinical success PIP joints Clinical success N n (%) N n (%) 24 h after CCH injection 325 213 (66) 211 62 (29) 48 h after CCH…